Pfizer will soon present its balance sheet figures for the recently ended quarter. Analysts predict this.
Pfizer will open its books on February 3, 2026 for the quarter ended December 31, 2025.
The average forecast from 17 analysts is for EPS of $0.567 per share for the most recent quarter. A year earlier, Pfizer had earnings per share of USD 0.070 on its books.
On average, 16 analysts expect sales to decline by 5.15 percent to USD 16.85 billion. In the same quarter last year, sales of $17.76 billion were on the books.
The forecasts of 23 analysts for the past fiscal year amount to average earnings per share of USD 3.12, compared to USD 1.41 per share in the previous corresponding period. In terms of annual sales, 22 analysts expect an average of USD 61.94 billion compared to USD 63.63 billion in the previous fiscal year.
Editorial team finanzen.net
By the way: Pfizer and other US stocks can even be traded on finanzen.net ZERO until 11 p.m. (without order fees, plus spreads). Open a depot now for free and secure a new customer bonus!
Selected leveraged products on Pfizer
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Pfizer
The leverage must be between 2 and 20
Advertising
